MENU
OCT 13, 2021 Opens: 5:30 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Coronavirus Virtual Event Series

A novel coronavirus emerged in China in late 2019; it has been officially named by the World Health Organization (WHO) as COVID-19. LabRoots will be working to educate the community about this pathogen in an ongoing series of virtual events.

Our 2020 Coronavirus Virtual Event Series including (4/2, 6,17, 9/17 and 12/3 events) were indeed a tremendous success!  The event (s) are now available for on-demand viewing. Our next set of presentations will go live on April 14th, 2021.

June 17th Keynote Speaker: Stephen S. Morse, PhD, FAAM, F.A.C.E.

This virus is a member of the coronavirus family and is zoonotic, or transmissible from animals to humans, and is thought to have originated in bats like other coronaviruses. Researchers are working to learn more about how this virus made the jump from animals to humans, probably through an intermediate species.

The COVID-19 virus has already infected tens of thousands of people worldwide. In China, hundreds have been killed, leading the World Health Organization to declare an international health emergency, one of only four that have ever been declared.

Researchers have found evidence that the virus can be transmitted by people that don't have symptoms. Scientists are working to find ways to treat the fever, respiratory illness, cough, and breathing difficulties it causes.

You can learn more from this event about:

  • The Origins and Symptoms of the virus
  • Testing, Research, and Diagnostics
  • Clinical Manifestations of COVID-19
  • Prevention, Containment, and Transmission
  • Vaccines (host immune response - clinical outcomes with vaccines)

This free event does not require any travel, and will remain ongoing; webinars will continue to occur in the future as we find out more about this pathogen. The content will be available for unlimited, on-demand viewing. The global community will be able to interact using chat sessions and live-streaming. This seamless connectivity will be available on any desktop or mobile device so you can view, learn, and interact.

Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the Coronavirus Virtual Event Series and virtual event. Submission is free. Submit your abstract here.

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this virtual event series, you can earn 1 Continuing Education credit per presentation.

Use #LRcoronavirus to follow the conversation!


Speakers

Show Resources
You May Also Like
JUN 08, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUN 08, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
The global pandemic has not only changed our plans for how we live and work, but also accelerated the need for innovation to protect human health. Join us for an Innovation Summit to hear fi...
JUN 17, 2021 3:00 PM BST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUN 17, 2021 3:00 PM BST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Each step in a diagnostic test's journey-from raw material extraction to patient administration-can influence outcomes....
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 8th Annu...
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Thirteen years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2022 Clinical Diagnostics and Research Virtual Event will again bring together clinic...
Agenda
  • APR 14, 2021 6:00 AM PDT
    Eugenia Z. Ong, PhD, Joe Poh Sheng Yeong, MBBS PhD Mmed (Path)
    Sponsored By: NanoString Technologies
    Eugenia Z. Ong, PhD
    Senior Research Fellow, Duke-NUS Medical School Singapore
    Joe Poh Sheng Yeong, MBBS PhD Mmed (Path)
    Associate Faculty, Institute of Molecular and Cell Biology (A*STAR) Singapore
  • Novel, high throughput test for detection of SARS-Cov-2 neutralizing antibodies
    APR 14, 2021 6:00 AM PDT
    Shuting Xu, PhD
    Field Appication Scientist
    Sponsored By: GenScript
  • Keynote Presentation: The impact of the New COVID-19 Variants and Vaccine Rollout on the pandemic
    APR 14, 2021 7:30 AM PDT
    Ali H. Mokdad, PhD
    Chief Strategy Officer, Population Health, University of Washington
  • Keynote Presentation: What the NIH Serosurvey Tells Us So Far and Why We Should Try to Develop a Broadly Protective/Universal Beta-Coronavirus Vaccine
    APR 14, 2021 9:00 AM PDT
    Matthew J. Memoli, MD, MS
    Director, LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Keynote Presentation: New Vaccine and Antiviral Strategies for COVID-19
    APR 14, 2021 10:30 AM PDT
    Adolfo Garcia-Sastre, PhD
    Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai
  • APR 14, 2021 12:00 PM PDT
    Russell Garlick, PhD, Nathan A. Ledeboer, PhD
    Sponsored By: LGC Seracare
    Russell Garlick, PhD
    Chief Scientific Officer, LGC SeraCare
    Nathan A. Ledeboer, PhD
    Professor and Vice Chair, Pathology; Medical Director, Medical College of Wisconsin
  • Solutions for SARS-CoV-2 Strain Lineage Surveillance
    APR 14, 2021 12:00 PM PDT
    Stephen Jackson
    Associate Director, Product Applications Genetic Sciences Division, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • APR 14, 2021 1:30 PM PDT
    Anthony Tong, PhD, Subodh Nimkar
    Sponsored By: BGI Americas
    Anthony Tong, PhD
    Director of Product Management, BGI
    Subodh Nimkar
    Senior Product Manager, Complete Genomics Facility, MGI
  • Molecular Testing for the Detection and Strain Identification of SARS-CoV-2
    APR 14, 2021 1:30 PM PDT
    Manohar R. Furtado, PhD
    Director R&D, Thermo Fisher Scientific, Genetic Testing Solutions
    Sponsored By: Thermo Fisher Scientific
  • NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit
    APR 14, 2021 3:00 PM PDT
    Pedro Echave, PhD
    Global Leader, NGS Product Experts, PerkinElmer
    Sponsored By: PerkinElmer
  • Quick and Easy Sequencing of SARS-CoV-2 to Identify Variants of Concern
    APR 14, 2021 3:00 PM PDT
    Jordan RoseFigura, PhD
    Director of Material Sciences, Swift Biosciences
    Sponsored By: Swift Biosciences
  • How RT-PCR Testing Allows Labcorp to Perform National SARS-CoV-2 Pandemic Surveillance
    APR 14, 2021 4:30 PM PDT
    Brian Krueger, PhD
    Associate Vice President, Research and Development, Laboratory Corporation of America
    Sponsored By: PacBio
The following webinars will be readily on-demand when the event starts
  • Clarigene: a Pandemic Diagnostic Story
    Michael Risley, PhD
    Chief Development Officer, Yourgene Health
  • Is SNP Genotyping a Better Approach for Monitoring for Known Variants of Concern
    Richard Michelmore
    Distinguished Professor and Director, The Genome Center, Genome and Biomedical Sciences Facility, University of California, Davis
  • New Technologies for Accessible, Durable and Broadly Protective Coronavirus Vaccines
    Corey Casper, M.D., MPH
    CEO, IDRI; Clinical Professor of Medicine and Global Health, University of Washington; Affiliate Professor, Vaccine and Infectious Disease Division, Fred Hutch Cancer Research Center
  • SARS-CoV-2 - Dynamics of the COVID-19 Epidemic
    Harm van Bakel, PhD
    Assistant Professor of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai
  • The Next Big Question: Genomic Surveillance of SARS-CoV-2
    Gary Schroth, Ph.D.
    Vice President and Distinguished Scientist, Illumina
  • The Rapid Development of COVID-19 Vaccines
    Paul Goepfert
    Professor of Medicine, University of Alabama at Birmingham Director, Alabama Vaccine Research Clinic (AVRC)
  • Keynote Presentation: Facial Masking for COVID-19: Transmission, Severity and Immunity
    DEC 03, 2020 6:00 AM PST
    Monica Gandhi, MD, MPH
    Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine, UCSF, Director, UCSF-Gladstone Center for AIDS Research (CFAR)
  • Keynote Presentation: Prevalence of SARS-CoV-2 Immunity in Those Undiagnosed with COVID-19 in the U.S.
    DEC 03, 2020 7:30 AM PST
    Matthew J. Memoli, MD, MS
    Director, LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • New! PerkinElmer® RT-PCR SARS-CoV-2 Solution Updates
    DEC 03, 2020 9:00 AM PST
    Arvind Kothandaraman
    General Manager, Specialty Diagnostics
    Sponsored By: PerkinElmer
  • Transmission Dynamics of SARS-CoV-2: Inference and Projection
    DEC 03, 2020 9:00 AM PST
    Jeffrey Shaman
    Professor of Environmental Health Sciences, Columbia University Mailman School of Public Health
  • Keynote Presentation: COVID-19 Projections for the United States
    DEC 03, 2020 10:00 AM PST
    Ali H. Mokdad, PhD
    Chief Strategy Officer, Population Health, University of Washington
  • Accelerating vaccine development using a next generation microfluidic CE platform
    DEC 03, 2020 10:30 AM PST
    Jeray Thelwell
    Mid-Atlantic and Southeast Biotherapeutics Solution Specialists
    Sponsored By: PerkinElmer
  • DEC 03, 2020 10:30 AM PST
    Arutha Kulasinghe, PhD, Miguel Muñoz-Ruiz, PhD
    Sponsored By: NanoString Technologies
    Arutha Kulasinghe, PhD
    Peter Doherty NHMRC Early Career Fellow at the Queensland University of Technology (QUT)
    Miguel Muñoz-Ruiz, PhD
    PostDoc fellow at the Immunosurveillance Lab at the Francis Crick Institute
  • DEC 03, 2020 12:00 PM PST
    Russell Garlick, PhD, Marc Salit, PhD
    Sponsored By: LGC Seracare
    Russell Garlick, PhD
    Chief Scientific Officer, LGC SeraCare
    Marc Salit, PhD
    Director, Joint Initiative for Metrology in Biology, Stanford University
  • Using an ARIES® Laboratory Developed Test for SARS-CoV-2 to Respond to the COVID-19 Pandemic in Louisville, KY
    DEC 03, 2020 1:30 PM PST
    Leslie A. Wolf, PhD, HCLD (ABB)
    Division of Infectious Diseases | University of Louisville
    Sponsored By: LUMINEX
  • Novel SARS-Cov-2 Neutralization Antibody test, performance and applications
    DEC 03, 2020 3:00 PM PST
    Roumen Bogoev
    Director, Catalog Products, GenScript USA Inc
    Sponsored By: GenScript
  • An Iterative Approach to Structure-based in silico to in vivo Development of Combinatorial Anti-SARS-CoV-2 Therapy
    DEC 03, 2020 4:30 PM PST
    Garth Ehrlich, PhD, FAAAS
    Professor of Microbiology & Immunology, Professor of Otolarynology-Head and Neck Surgery, Drexel University College of Medicine
The following webinars will be readily on-demand when the event starts
  • COVID-19 RNA and DNA vaccines
    Deborah Fuller, PhD
    Professor, Department of Microbiology, University of Washington School of Medicine, Division Chief, Infectious Diseases and Translational Medicine, Washington National Primate Research Center
  • Development, assessment and commercialization of serological SARS CoV-2 tests - an interdisciplinary success story
    Dr. Mark Dürkop
    CEO Novasign GmbH, Project Lead BOKU - Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna
  • Immunity, Aging and COVID-19 : where do we stand?
    Janko Nikolich-Zugich, MD, PhD
    Bowman Professor and Head, Department of Immunobiology, Co-Director, University of Arizona Center on Aging, University of Arizona College of Medicine-Tucson
  • NGS Workflows for Studying Infectious Disease
    Gary P. Schroth, PhD
    Vice President and Distinguished Scientist, Illumina, Inc.
  • Putting COVID-19 Into Context
    Amesh A. Adalja, MD
    Senior Scholar, Johns Hopkins Center for Health Security
  • Recent insights into SARS-CoV-2 intra-host population dynamics
    Todd Treangen
    Assistant Professor, Computer Science, Rice University, Co-Lead COVID-19 International Research Team (COV-IRT)
  • Keynote Presentation: The American Response to COVID-19: what went right, what went wrong
    SEP 17, 2020 6:00 AM PDT
    Ashish K. Jha, M.D., M.P.H.
    Dean, Brown University School of Public Health
  • Keynote Presentation: IHME Covid-19 projections for the US: Strategies to reduce the spread
    SEP 17, 2020 7:30 AM PDT
    Ali H. Mokdad, PhD
    Chief Strategy Officer, Population Health, University of Washington
  • Coronaviruses: History, Biology and Innate Immune Antagonism
    SEP 17, 2020 9:00 AM PDT
    Susan R. Weiss, PhD
    Professor and Vice Chair Department of Microbiology, Co-Director, Penn Center for Research on Coronaviruses and Other Emerging Pathogens Perelman school of Medicine University of Pennsylvania
  • Preclinical Optical Imaging of Infectious Diseases
    SEP 17, 2020 9:00 AM PDT
    Kevin Francis, PhD
    Divisional VP, Biology Solutions at PerkinElmer
    Sponsored By: PerkinElmer
  • Purification of cells from SARS-CoV-2 convalescent samples and potentially infectious materials with fluorescent-activated cell sorting
    SEP 17, 2020 9:00 AM PDT
    Joe Ostrand, PhD
    Flow Cytometry Specialist, Miltenyi Biotec
    Sponsored By: Miltenyi Biotec
  • Keynote Presentation: Discovery of SARS-CoV-2 antivirals through large-scale repositioning studies
    SEP 17, 2020 10:00 AM PDT
    Sumit Chanda, PhD
    Director & Professor, Immunity & Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute
  • Host and Viral Transcriptomes During COVID-19 Infection
    SEP 17, 2020 11:00 AM PDT
    Christopher E. Mason, PhD
    Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction
  • SEP 17, 2020 11:00 AM PDT
    Mathis Laffenetre, Nicolas Pierre
    Sponsored By: PerkinElmer
    Mathis Laffenetre
    Life Sciences Technology Platform Metabolic Diseases Reagents Leader
    Nicolas Pierre
    Life Sciences Technology Platforms Leader, Discovery Reagents
  • Lung-Chip - Accelerating Study of Viral Infection and Therapeutics
    SEP 17, 2020 11:00 AM PDT
    Lorna Ewart, PhD
    EVP European Scientific Liaison Emulate, Inc.
    Sponsored By: Emulate Bio
  • Advanced NGS solutions for SARS-CoV-2 monitoring and insights
    SEP 17, 2020 12:00 PM PDT
    Cris Kinross
    Global Market Development, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • Antibody therapy against SARS-CoV-2: A Global Collaboration
    SEP 17, 2020 12:00 PM PDT
    Erica Ollmann Saphire, PhD
    Professor, La Jolla Institute for Immunology
  • Important considerations for choosing a SARS-CoV-2 assay
    SEP 17, 2020 12:00 PM PDT
    Arvind Kothandaraman
    General Manager, Specialty Diagnostics
    Sponsored By: PerkinElmer
  • Keynote Presentation: SARS-CoV-2 Susceptibility, Transmission and Reinfection in Domestic Cats
    SEP 17, 2020 1:00 PM PDT
    Jürgen A. Richt, DVM, PhD
    Regents Distinguished Professor at KSU, University Distinguished Professor, Director - Center on Emerging & Zoonotic Infectious Diseases (CEZID), NIH Center of Biomedical Research Excellence
  • SEP 17, 2020 2:00 PM PDT
    Jacqueline Fabius, Nevan Krogan, PhD
    Jacqueline Fabius
    Chief Operating Officer, Quantitative Biosciences Institute (QBI)
    Nevan Krogan, PhD
    Professor of Cellular and Molecular Pharmacology, UCSF, Principal Investigator, Gladstone Institute of Data Science and Biotechnology, Director of the Quantitative Bioscience Institute
  • Discovery of a druggable pocket in SARS-CoV-2 Spike: New avenue to defeat COVID-19?
    SEP 17, 2020 3:30 PM PDT
    Imre Berger
    Founder and Managing Director of the Max Planck Bristol Centre for Minimal Biology
    Sponsored By: GenScript
  • Repurposing in COVID-19: Can we identify new antivirals
    SEP 17, 2020 3:30 PM PDT
    Sara Cherry, PhD
    Professor of Pathology and Laboratory Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania
  • SEP 17, 2020 3:30 PM PDT
    Russell Garlick, PhD, Richard Hughes, Joel Lefferts, PhD, HCLD, DABCC
    Sponsored By: LGC Seracare
    Russell Garlick, PhD
    Chief Scientific Officer, LGC SeraCare
    Richard Hughes
    Associate Scientific Director at LGC
    Joel Lefferts, PhD, HCLD, DABCC
    Assistant Professor of Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth and Assistant Director, Clinical Genomics and Advanced Technology (CGAT) Laboratory
  • SEP 17, 2020 4:30 PM PDT
    Sean Nolan, Patrick Raber, PhD, Thomas Snyder, PhD
    Sponsored By: Adaptive Biotechnologies
    Sean Nolan
    Distinguished Engineer
    Patrick Raber, PhD
    Senior Manager, Research and Business Development
    Thomas Snyder, PhD
    VP, Research, immunoSEQ Dx
  • Ultra-fast one-step RT-PCR protocol for the detection of SARS-CoV-2
    SEP 17, 2020 4:30 PM PDT
    Brian McNally, PhD
    Chief Commercial Officer, Molecular Biology Systems, BV
The following webinars will be readily on-demand when the event starts
  • Insights into SARS-CoV-2 Biology
    Adolfo Garcia-Sastre, PhD
    Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai
  • Testing for SARS-CoV-2: The Cleveland Clinic Experience
    Gary Procop, MD, MS
    Medical Director & Co-Chair, Enterprise Laboratory Stewardship Committee, Enterprise Medical Operations, & Director of Microbiology, Virology, Mycology & Parasitology, Clevelaland Clinic
  • The detection, characterization, and surveillance of the SARS-CoV-2 viral genome using hybridization capture-based NGS assay
    Dorottya Nagy-Szakal, MD PhD
    Chief Medical Officer, Biotia, Research Assistant Professor, Department Cell Biology/College of Medicine, SUNY Downstate Health Sciences University
  • JUN 17, 2020 6:00 AM PDT
    Cris Kinross
    Global Market Development, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • JUN 17, 2020 6:00 AM PDT
    Steve Angeloni, Nicole Pecora, MD, PhD
    Sponsored By: LUMINEX
    Steve Angeloni
    Senior Field Applications Scientist, Luminex
    Nicole Pecora, MD, PhD
    Assistant Professor in Pathology and Laboratory Medicine at the University of Rochester Medical Center in Rochester NY
  • JUN 17, 2020 6:00 AM PDT
    Linfa Wang, PhD
    Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
    Sponsored By: GenScript
  • JUN 17, 2020 7:30 AM PDT
    Joel Guthridge, PhD, Petter Brodin, MD, PhD
    Sponsored By: Fluidigm
    Joel Guthridge, PhD
    Assistant Member, Arthritis and Clinical Immunology Director of Translational Informatics, Clinical Resources, Biorepository and Human Phenotyping Cores, Oklahoma Medical Research Foundation
    Petter Brodin, MD, PhD
    Associate Professor and consultant physician Science for Life Laboratory, Karolinska Institutet Department of Pediatric Rheumatology, Karolinska University Hospital, Stockholm
  • JUN 17, 2020 7:30 AM PDT
    Imad Tarhoni, MD, PhD
    Postdoctoral Fellow at Rush University Medical Center in Chicago
    Sponsored By: LUMINEX
  • JUN 17, 2020 7:30 AM PDT
    Gabriel Fernandez de Pierola, Christopher Norey, PhD
    Sponsored By: Cytiva
    Gabriel Fernandez de Pierola
    General Manager - Genomics & Diagnostic Solutions Cytiva (formerly GE Life Sciences)
    Christopher Norey, PhD
    R&D Leader, Cytiva (formerly GE Healthcare Life Sciences)
  • JUN 17, 2020 9:00 AM PDT
    Stephen S. Morse, PhD, FAAM, F.A.C.E.
    Professor of Epidemiology, Director, Infectious Disease Epidemiology Certificate, Columbia University, Mailman School of Public Health
  • JUN 17, 2020 10:30 AM PDT
    Haley R. Pugsley, PhD, Kamala Tyagarajan, PhD
    Sponsored By: LUMINEX
    Haley R. Pugsley, PhD
    Manager, Senior Scientist
    Kamala Tyagarajan, PhD
    Director, Flow Cytometry Assays & Application
  • JUN 17, 2020 10:30 AM PDT
    Arvind Kothandaraman
    General Manager, Specialty Diagnostics
    Sponsored By: PerkinElmer
  • JUN 17, 2020 10:30 AM PDT
    Jiahui Yang, PhD
    Director, R&D, Sino Biological
    Sponsored By: Sino Biological, Inc.
  • JUN 17, 2020 12:00 PM PDT
    Susan Zolla-Pazner, PhD
    Professor of Medicine, Division of Infectious Diseases Icahn School of Medicine at Mount Sinai
    Sponsored By: LUMINEX
  • JUN 17, 2020 12:00 PM PDT
    Aaron P. Benfield, PhD, Sherry A. Dunbar, PhD, MBA
    Sponsored By: LUMINEX
    Aaron P. Benfield, PhD
    Senior Director, Molecular Applications
    Sherry A. Dunbar, PhD, MBA
    Senior Director, Global Scientific Affairs
  • JUN 17, 2020 12:00 PM PDT
    Klaus Hochleitner, PhD, Brendan O'Farrell, PhD, Darren Rowles, David Wilson, Lee Jenkins
    Sponsored By: Cytiva
    Klaus Hochleitner, PhD
    Global Technology Lead, Diagnostics, Cytiva
    Brendan O'Farrell, PhD
    President and Co-Founder, DCN Diagnostics
    Darren Rowles
    President and CEO, Sona Nanotech
    David Wilson
    Commercial Director, Diagnostics, Avacta Life Sciences
    Lee Jenkins
    Senior Product Leader, Cytiva
  • JUN 17, 2020 1:30 PM PDT
    Dan Gibson, PhD, Krishna Kannan, PhD, Katie Lyons, MS
    Sponsored By: Codex DNA
    Krishna Kannan, PhD
    Staff Scientist
    Katie Lyons, MS
    Sr. Scientist
  • JUN 17, 2020 1:30 PM PDT
    Joseph M. Beechem, PhD, Christopher E. Mason, PhD, Robert E. Schwartz, PhD
    Sponsored By: NanoString Technologies
    Joseph M. Beechem, PhD
    CHIEF SCIENTIFIC OFFICER AND Senior Vice President Of Research and Development, NANOSTRING TECHNOLOGIES
    Christopher E. Mason, PhD
    Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction
    Robert E. Schwartz, PhD
    Assistant Professor of Medicine, Weill Medical College of Cornell University
  • JUN 17, 2020 1:30 PM PDT
    Rob Kozak, PhD FCCM
    Clinical Microbiologist, Sunnybrook Health Sciences Centre, Associate Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
  • JUN 17, 2020 3:00 PM PDT
    Jeray Thelwell
    Mid-Atlantic and Southeast Biotherapeutics Solution Specialists
    Sponsored By: PerkinElmer
  • JUN 17, 2020 3:00 PM PDT
    Marcello Stein, PhD
    Global Product Manager and Group Leader Immunology T cells
    Sponsored By: Miltenyi Biotec
  • JUN 17, 2020 3:00 PM PDT
    Matthew Flegal, BS, SRS
    Senior Manager InVivo Sciences, Charles River
  • JUN 17, 2020 4:30 PM PDT
    Andrius Kočevas
    Product Manager, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • JUN 17, 2020 4:30 PM PDT
    Todd Treangen
    Assistant Professor, Computer Science, Rice University, Co-Lead COVID-19 International Research Team (COV-IRT)
The following webinars will be readily on-demand when the event starts
  • Jamie Phillips, MS, PhD
    Sr. Scientific Affairs Manager, Roche Diagnostic Corporation
  • Shonali Paul, MBA
    Chief Operating Officer, CloudLIMS.com
  • APR 02, 2020 6:00 AM PDT
    Bill Hunt, MS, Andrew Quong, PhD
    Sponsored By: Fluidigm
    Bill Hunt, MS
    Director, Microfluidics Product Management, Fluidigm
    Andrew Quong, PhD
    Chief Science Officer, Fluidigm
  • APR 02, 2020 6:00 AM PDT
    Cris Kinross
    Global Market Development, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • APR 02, 2020 7:30 AM PDT
    Rowshanak Hashemiyoon, PhD
    Clinical Scientist, Author, Consultant
  • APR 02, 2020 7:30 AM PDT
    Linfa Wang, PhD
    Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
  • APR 02, 2020 8:30 AM PDT
    Yi-Wei Tang, MD, PhD, F(AAM), FIDSA
    China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai
  • APR 02, 2020 8:30 AM PDT
    Anupam Singhal
    Product Manager, Antibody Therapeutics, Berkeley Lights, Inc.
    Sponsored By: Berkeley Lights
  • APR 02, 2020 10:00 AM PDT
    Jun Wu, PhD
    Associate Professor, Pathology, Vice Director of Clinical Laboratory Medicine Center, Shanghai General Hospital, affiliated to Shanghai Jiaotong University
  • APR 02, 2020 10:00 AM PDT
    Mark Denison, MD
    Director, Division of Infectious Diseases, Craig-Weaver Professor of Pediatrics, Professor of Pathology, Microbiology & Immunology, Professor at Vanderbilt University
    Continuing Education: Florida CE | P.A.C.E. CE
  • APR 02, 2020 11:30 AM PDT
    Manzhu Kang, PhD, Sean Taylor
    Sponsored By: GenScript
    Manzhu Kang, PhD
    Senior Scientist of Antibody Research Group at GenScript ProBio
    Sean Taylor
    Manager of the Field Applications Group at GenScript USA, Inc
  • APR 02, 2020 11:30 AM PDT
    Li Jiang, MD, PhD
    Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Sichuan Provincial Center for Clinical Laboratories (SPCCL)
  • APR 02, 2020 1:00 PM PDT
    Jason Chen, MD, Yushen Jiang, MD, Ruben Luo, PhD, Chengbin Wang, MD, Frank Yang, MD, PhD
    Jason Chen, MD
    Head of Virology Unit of KingMed Diagnostics
    Yushen Jiang, MD
    Deputy Director of Central Lab of DIAN Diagnostics
    Ruben Luo, PhD
    NACCCA Board Secretary, Clinical Fellow of UC San Francisco
    Chengbin Wang, MD
    Chairman of Chinese Society of Laboratory Medicine, Director of Clinical Laboratory of PLA General Hospital, Chief Physician
    Frank Yang, MD, PhD
    Pathologist (ABP-AP/CP, Hem), Vice President of ADICON Medical Laboratories
  • APR 02, 2020 1:00 PM PDT
    Geert Koene, PhD
    Biosearch Technologies Market Segment Manager MDx, LGC
    Sponsored By: Biosearch Technologies
  • APR 02, 2020 2:30 PM PDT
    Subodh Nimkar, Pan Zhang, PhD
    Sponsored By: BGI Americas,
    MGI Americas
    SEE ABSTRACT | Sponsored by: MGI Americas | Continuing Education: Florida CE | P.A.C.E. CE
    Subodh Nimkar
    Senior Product Manager, Complete Genomics Facility, MGI
    Pan Zhang, PhD
    Laboratory Director at BGI
The following webinars will be readily on-demand when the event starts
  • APR 02, 2020 2:30 PM PDT
    Meredith Ashby, PhD
    Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
    Sponsored By: PacBio
Speakers
  • Brian Krueger, PhD
    Associate Vice President, Research and Development, Laboratory Corporation of America
    Biography

      Brian Krueger, PhD, is an Associate Vice President and Technical Director in R&D at Labcorp. His areas of focus are high throughput exome and genome sequencing, Molecular Microbiology, and high throughput lab automation. He and the Molecular Microbiology R&D group at Labcorp developed and received FDA Emergency Use Authorization for the LabCorp COVID-19 RT-PCR Test.  Recently, Labcorp was awarded a SARS-CoV-2 sequencing surveillance contract with the CDC as a direct result of the R&D team's work in sequencing and characterizing thousands of viral genomes from early on in the pandemic. Dr. Krueger received his PhD in Molecular and Cellular Biology from the University of Iowa in 2009.  He then spent 3 years at the University of Florida employing genetic manipulation and high throughput sequencing techniques to create hundreds of viral mutants of Kaposi Sarcoma Herpesvirus and Murine Herpesvirus 68.  In 2012, Dr. Krueger transitioned from viruses to humans and spent 3 years overseeing Dr. David Goldstein's high throughput human genetics sequencing lab at Duke University and transitioned that lab to Columbia University Medical Center in 2014. He joined Labcorp in 2015 where he has continued to focus on diagnostic assay development in both rare disease genetics and infectious disease.

    • Jordan RoseFigura, PhD
      Director of Material Sciences, Swift Biosciences
      Biography

        Dr. Jordan RoseFigura completed her Ph.D. in Chemistry at UC Berkeley where she studied the mechanism of PQQ formation. After that, she was an NIH Postdoctoral Fellow at The Rockefeller University where she investigated small molecule inhibition of bacterial infection. At Swift, Jordan focuses on targeted sequencing and custom projects. She leads the custom amplicon laboratory and also works to develop new targeted technologies. Since starting at Swift, she has developed the Swift Normalase® Amplicon Panel (SNAP) workflow, 8 off-the-shelf amplicon panels, and the Swift indexes.

      • Pedro Echave, PhD
        Global Leader, NGS Product Experts, PerkinElmer
        Biography

          Pedro Echave has a Ph.D. in Biochemistry with more than 10 years of experience in genomic projects. He joined PerkinElmer 2 years ago as an NGS specialist for the EMEA region. As of May 2020, he has been serving as a Global Product Specialist for NGS. 

        • Subodh Nimkar
          Senior Product Manager, Complete Genomics Facility, MGI
          Biography

            Subodh Nimkar is a Senior Product Manager in MGI based in Complete Genomics facility in San Jose CA. His primary responsibilities include management and commercialization of the novel CoolMPS Chemistry for Massively Parallel Sequencing on DNBSEQ platforms. He is also responsible for product management and commercialization of MGIs sequencing solutions in AMERICAS. Over last 20 years he has worked with ABI, Thermo Fisher, Agilent and Streck. He has authored two key patents at ABI and commercialized solutions based on that. He holds a Masters in Chemical Engineering and MBA.

          • Anthony Tong, PhD
            Director of Product Management, BGI
            Biography

              Anthony Tong is a Director of Product Management at BGI Americas. He has broad experience in the genomics and diagnostics space, covering oncology and infectious disease testing, companion diagnostics, biomarker and diagnostics development, and non-invasive prenatal testing. He currently leads product marketing for BGI's COVID-19 solution and previously managed the company's NGS solution for the biopharma industry in North America. Anthony received his PhD in Chemical Engineering from Columbia University and MBA from University of California, San Diego. 

            • Manohar R. Furtado, PhD
              Director R&D, Thermo Fisher Scientific, Genetic Testing Solutions
              Biography

                Manohar Furtado is a Director for R & D at Thermo Fisher Scientific. He has been working in the Life Sciences & Clinical Diagnostics for over 25 years. He has a PhD in Biology from the University of Poona and a Business Certification from the Sloan School of Management at MIT. Dr. Furtado worked as an Assistant Professor of Infectious Diseases & Pathology, the Director for Biotechnology, and the CLIA lab Director. He was with Applied Biosystems and Life Technologies in R & D for 13 years. He was on the National Biodefense Science Board at DHHS to implement bio surveillance policies. He has been involved in discovery research, clinical diagnostic testing, product development and commercialization, M & A activity with key acquisitions, fund raising and in defining strategy. He has been the recipient of several grants from funding agencies, has over 90 publications, and has presented at over 200 conferences on various topics related to human health and safety.

              • Russell Garlick, PhD
                Chief Scientific Officer, LGC SeraCare
                Biography

                  Russell Garlick, PhD, is the Chief Scientific Officer at LGC SeraCare Life Sciences. Since 2012 he has been focusing on expanding the company's technologies, R&D organization, and product development pipeline. Throughout his career he has worked on the development, regulatory approval, and launch of a variety of technologies and assays, including an HIV/AIDS patient management program, molecular genomics technologies, and HIV drug discovery systems. Prior to joining LGC Clinical Diagnostics, Dr. Garlick was co-founder of Life Sciences Group and served as CEO and CTO of Protein Forest, Inc. He has also held executive R&D positions at PerkinElmer Life Sciences and DuPont NEN Life Sciences.

                • Nathan A. Ledeboer, PhD
                  Professor and Vice Chair, Pathology; Medical Director, Medical College of Wisconsin
                  Biography

                    Nathan A. Ledeboer, PhD, is a Professor and Vice Chair of Pathology and Medical Director of Microbiology, Molecular Diagnostics, reference services, and Laboratory Client Services at Froedtert Hospital and Wisconsin Diagnostic Laboratories in Milwaukee, WI.  His research endeavors, particularly in the area developing diagnostic tools for infectious diseases, have led to numerous publications in peer-reviewed journals and more than 100 funded research projects.  Dr. Ledeboer is also a senior editor for the Journal of Clinical Microbiology.

                  • Stephen Jackson
                    Associate Director, Product Applications Genetic Sciences Division, Thermo Fisher Scientific
                    Biography

                      Dr. Jackson has over 10 years of experience in genetic analysis technologies. As a senior member of the Content Engine R&D team at Thermo Fisher Scientific, he helps develop solutions for the research and healthcare markets, leveraging varied technologies such as capillary electrophoresis, digital PCR, next-generation sequencing, and microarray analysis. Before Thermo Fisher Scientific, he was at Nanostring Technologies running the Field Applications Specialist (FAS) team. He was also an Acting Assistant Professor at University of Washington, Department of Genome Sciences, investigating developmental genetics of Drosophila melanogaster.

                    • Adolfo Garcia-Sastre, PhD
                      Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai
                      Biography
                        Dr. García-Sastre is Professor in the Departments of Microbiology and Medicine and in the Tisch Cancer Center at Icahn School of Medicine Mount Sinai (ISMMS) in New York,. He is also Director of the Global Health and Emerging Pathogens Institute at ISMMS, and Principal Investigator for the Center for Research on Influenza Pathogenesis (CRIP), one of five NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS). For the past 30 years, his research interest has been focused on the molecular biology, virus-host interactions, innate immunity and pathogenesis of influenza viruses and several other RNA viruses, as well as on the development of new vaccines and antivirals. He has more than 500 peer-reviewed publications in these areas of research. He has been President of the International Society for Vaccines in 2014-2015. He is Editor for the scientific journals PLoS Pathogens, Journal of Virology and Virus Research. In 2017, he has been elected a fellow of the Royal Academy of Pharmacy in Spain. In 2019, he was recognized with a Honorary Doctor Degree from the University of Burgos, Spain. Also in 2019, he was elected a member of the National Academy of Sciences.
                      • Matthew J. Memoli, MD, MS
                        Director, LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
                        Biography

                          Dr. Memoli is a graduate of the College of William and Mary and he received his master's degree in microbiology from Thomas Jefferson University in Philadelphia, PA. He then received his medical degree from St George's University School of Medicine. He completed a residency in internal medicine at the Washington Hospital Center Georgetown University Internal Medicine Program in Washington, DC. After completing an infectious disease fellowship in NIAID at the National Institutes of Health, Dr. Memoli developed a clinical/translational research program to study influenza and other respiratory viruses in the Laboratory of Infectious Diseases. He now serves as the Director of the LID Clinical Studies Unit (CSU) that seeks to perform translational research studies to answer fundamental questions regarding human influenza, respiratory viruses, and other emerging viral infections to inform and impact future vaccine and therapeutic design, while also making an effort to assist in evaluation of novel products that may impact human health. With a focus on healthy volunteer research, the LID CSU has been able to continue their primary work on influenza while quickly able to respond to assist in research of emerging infections.  Dr. Memoli is considered a leading expert in healthy volunteer challenge trials, respiratory virus infections, and influenza vaccines. In addition, in recent years Dr. Memoli's LID CSU has been heavily involved in the NIH response to emerging threats including the 2009 Influenza Pandemic, Zika, EBOLA, and COVID19.

                        • Ali H. Mokdad, PhD
                          Chief Strategy Officer, Population Health, University of Washington
                          Biography

                            Ali H. Mokdad, PhD, is Professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) and Chief Strategy Officer for Population Health at the University of Washington. Prior to IHME, Dr. Mokdad worked at the US Centers for Disease Control and Prevention. He has published groundbreaking research on local-level disease trends and leading risk factors for poor health. His work on obesity is among the most highly cited in the field.

                          • Shuting Xu, PhD
                            Field Appication Scientist
                            Biography

                              Dr. Shuting Xu received her PhD degree from Hanover medical school in Germany. Before, she holds a Master's degree in Biology from University of Ulm, Germany and a Bachelor's degree in Biology from Nanjing Agricultural University. Her research during PhD and Postdoc periods were mainly focused on virus-related innate immune response and HIV-1 restriction factors. Her publication "cGAS-Mediated Innate Immunity Spreads Intercellularly through HIV-1 Env-Induced Membrane Fusion Sites" on Cell Host & Microbe has received the German AIDS prize that year. Dr. Xu currently works at GenScript Europe as Field Application Scientist.

                            • Eugenia Z. Ong, PhD
                              Senior Research Fellow, Duke-NUS Medical School Singapore
                            • Joe Poh Sheng Yeong, MBBS PhD Mmed (Path)
                              Associate Faculty, Institute of Molecular and Cell Biology (A*STAR) Singapore
                            • Harm van Bakel, PhD
                              Assistant Professor of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai
                              Biography

                                Harm van Bakel, PhD, is an Assistant Professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai (ISMMS) and co-director of the Mount Sinai Health System Pathogen Surveillance Program. His research interests are focused on applying novel genomics technologies to fundamental problems in infectious disease to understand pathogen-host interactions and the molecular basis of evolution and transmission of viruses and bacteria, to ultimately provide insights into new treatment options and approaches to prevent the spread of infectious diseases.

                              • Gary Schroth, Ph.D.
                                Vice President and Distinguished Scientist, Illumina
                                Biography

                                  Dr. Schroth is currently a Vice President and Distinguished Scientist at Illumina where he leads the Emerging Applications Group in Product Development.  He has been with Illumina for 16 years. Dr. Schroth works on developing NGS tools to study genomics, gene expression and regulation and applies these tools to projects in the fields of cancer, immunology, microbiology and infectious disease.  Over the course of his career Dr. Schroth has been an author on more than 100 peer reviewed research papers and holds 17 U.S. patents.

                                • Richard Michelmore
                                  Distinguished Professor and Director, The Genome Center, Genome and Biomedical Sciences Facility, University of California, Davis
                                  Biography

                                    After studying Natural Sciences at Cambridge University, Richard Michelmore joined the faculty of University of California at Davis in 1982. Richard was the founding Director of the Genome Center at UC Davis in 2003. He is currently a Distinguished Professor in the Departments of Plant Sciences, Molecular & Cellular Biology, and Medical Microbiology & Immunology. His multidisciplinary research utilizes molecular, genetic, and evolutionary approaches to plant genomics and he has published over 200 scientific papers. In particular, he aims to exploit such approaches for information-driven deployment of resistance genes in crop plants to provide more durable disease resistance. In addition, he is interested in fostering research to enhance global food security. His interests also include applications of DNA sequencing to all areas of biology and its increasing impact on society. In response to the current pandemic, he has been a major contributor to the team providing rapid, high throughput testing for SARS-CoV-2 to the UC Davis campus and the City of Davis and is now deploying rapid genotyping to monitor for variants of concern.

                                  • Corey Casper, M.D., MPH
                                    CEO, IDRI; Clinical Professor of Medicine and Global Health, University of Washington; Affiliate Professor, Vaccine and Infectious Disease Division, Fred Hutch Cancer Research Center
                                    Biography

                                      Corey Casper is the Chief Executive Officer at the Infectious Disease Research Institute (IDRI). At IDRI, Dr. Casper oversees a portfolio of vaccines, therapeutics, and diagnostics that provide co